Weight Loss, Category Gains - Corbion 2024 - 2

insights on how these medications affect taste
preferences, providing valuable information for
the food industry to better serve its consumers.
GLP-1 101
GLP-1 is a hormone produced by the small
intestine, and, among other functions, works
to slow stomach emptying, trigger insulin
release from the pancreas and block glucagon.
GLP-1 medications mimic the hormone to
change cravings and excessive food intake.
Prescriptions for GLP-1 drugs often require
pre-existing conditions such as Type 2 diabetes
or BMI-defined obesity. In general, the drugs are
becoming more commonly used: according to
recent Health Tracking Poll by the Kaiser Family
Foundation, about one in eight adults said that
they have " ever " taken a GLP-1 medication.
The proprietary research conducted by
Corbion this year affirms that branded GLP-1
medications are expanding in usage. Corbion's
research of GLP-1 users found that among those
using this class of drugs for weight loss, 65%
are on Ozempic, 13% are prescribed Mounjaro,
11% are taking Wegovy, 6% are Zepbound users
and 5% are on " other " GLP-1 medications.
The buzz around GLP-1s - and research studies
that support their effectiveness - is likely to
accelerate. BMO Capital Markets projects that
annual sales of weight loss drugs will reach $150
billion by 2033. The personalized healthcare
firm Accolade shared a survey showing that
GLP-1 coverage in employer plans is expected
to nearly double in 2024 compared to 2023.
GLP-1 users are consuming more protein now
than ever before, and far less sugar and fats.
GLP-1 Users for Weight Loss
Q: How has your consumption changed since starting GLP-1 medication
APPETITE FOR CHANGE
As more consumers are
prescribed weight loss drugs,
they are simultaneously
adjusting their food intake.
According to Corbion's
survey, 42% of people taking
these medications for weight
loss and/or Type 2 diabetes
management report that
they are eating less now
than ever, even while they
are becoming more active
and upping their exercise.
Certain food and
Less Now
About the Same
More Now
beverage categories are
more affected than others,
Corbion's research affirms.
Decreased appetites and
cravings cause some people
to avoid indulgent products
that were previously part
of their diets; Corbion's
data shows that 4 in 10

Weight Loss, Category Gains - Corbion 2024

Table of Contents for the Digital Edition of Weight Loss, Category Gains - Corbion 2024

Weight Loss, Category Gains - Corbion 2024 - 1
Weight Loss, Category Gains - Corbion 2024 - 2
Weight Loss, Category Gains - Corbion 2024 - 3
Weight Loss, Category Gains - Corbion 2024 - 4
Weight Loss, Category Gains - Corbion 2024 - 5
Weight Loss, Category Gains - Corbion 2024 - 6
https://www.nxtbookmedia.com